Allurion Technologies, Inc. develops treatments for obesity. The company is headquartered in Natick, Massachusetts and currently employs 134 full-time employees. The company went IPO on 2021-03-29. The firm offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
Allurion Technologies Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Allurion Technologies Inc 주요 수익원은 Allurion Balloon이며, 최신 수익 발표에서 수익은 32,110,000입니다. 지역별로는 All Other Countries이 Allurion Technologies Inc의 주요 시장이며, 수익은 24,039,000입니다.
Allurion Technologies Inc은 수익성이 있나요?
예, 최신 재무제표에 따르면 Allurion Technologies Inc의 순이익은 $32입니다.